🇺🇸 FDA
Patent

US 6783760

Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

expired A61KA61K39/395A61K47/6835

Quick answer

US patent 6783760 (Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 31 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61K, A61K39/395, A61K47/6835, A61K47/6849, A61K49/04